23 November 2021 - Paine Schwartz Partners has announced an investment in Hendrix Genetics.
Paine Schwartz Food Chain Fund V and affiliated co-investors will hold 50% ownership in the company. Hendrix Genetics’ Co-Founders, Thijs Hendrix and Antoon van den Berg, will also maintain a 50% ownership. Investment firm NPM Capital, a shareholder in Hendrix Genetics since 2015, will sell its minority interest as an integral part of the deal.
Founded in 2005 and headquartered in Boxmeer, The Netherlands, Hendrix Genetics has more than 3,500 employees and operations in more than 25 countries. The company has breeding programmes in turkeys, laying hens, traditional poultry, swine, salmon, trout and shrimp. Hendrix Genetics’ management team led by CEO Jolanda van Haarlem will continue operating the business.
“We are excited to partner with the Paine Schwartz team to build on our strong foundation and further grow by continuing to develop innovative solutions for the animal protein sector that meet the challenges of food production,” said Thijs Hendrix. “Following NPM Capital’s investment in 2015, this new investment from Paine Schwartz will help us to further accelerate growth through expansion into new markets and sustain our leadership in technology and R&D. This will result in driving the rapid improvement of genetics and breeding along with fundamental gains in genetic improvement for our customers."
Kevin Schwartz, CEO of Paine Schwartz, added: “This strategic investment in Hendrix Genetics is directly aligned with our long-term thesis of identifying companies that sustainably increase productivity in the production of agriculture commodities, which is required to feed an ever-growing global population. We are pleased to be joined in this investment by co-investors who also recognize the significant value creation opportunity ahead for Hendrix Genetics and its data and technology-enabled breeding programs.”
The deal is expected to close by the end of Q1 2022.
